Biocon

    OverviewSuggest Edit

    Biocon is a biopharmaceutical company focused on delivering healthcare solutions. It manufactures novel biologics, biosimilar insulins, and antibodies. The company aims to reduce therapy costs of diseases such as autoimmune, diabetes and cancer.

    TypePublic
    Founded1978
    HQBengaluru, IN
    Websitebiocon.com
    Employee Ratings3.8

    Latest Updates

    Employees (est.) (Jun 2019)7,995
    Job Openings63
    Cybersecurity ratingCMore

    Key People/Management at Biocon

    John Shaw

    John Shaw

    Vice Chairman and Non-Executive Director
    Mary Harney

    Mary Harney

    Independent and Non-Executive Director
    Vijay Kuchroo

    Vijay Kuchroo

    Independent and Non-Executive Director
    Ravi Mazumdar

    Ravi Mazumdar

    Non-Executive Director
    M. Damodaran

    M. Damodaran

    Independent and Non-Executive Director
    Siddharth Mittal

    Siddharth Mittal

    CEO and Managing Director
    Show more

    Biocon Office Locations

    Biocon has an office in Bengaluru
    Bengaluru, IN (HQ)
    Hosur Rd
    Show all (1)

    Biocon Online and Social Media Presence

    Embed Graph

    Biocon News and Updates

    Biocon Q4 Review - Subdued Biosimilars Impacted Performance: ICICI Securities

    Biocon Q4 Review - Subdued Biosimilars Impacted Performance: ICICI Securities

    Biocon Q4 Review - Biosimilars Performance Below Expectations: ICICI Direct

    Biocon Q4 Review - Biosimilars Performance Below Expectations: ICICI Direct

    Biocon partners with Libbs Farmaceutica to launch generic formulations in Brazil

    Biocon Pharma, a unit of the company, has tied up with Brazil-based Libbs Farmaceutica to introduce generic formulations in the Latin American country, Biocon Ltd said in a statement.

    Biocon - Commercialization Issues Impact Q3 Earnings: Motilal Oswal

    Biocon - Commercialization Issues Impact Q3 Earnings: Motilal Oswal

    Insights on the Biosimilar Global Market to 2026 - Featuring Allergan, Biocon and BioXpress Therapeutics Among Others

    Dublin, Jan. 21, 2021 (GLOBE NEWSWIRE) -- The "Biosimilar Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's offering. This report on the global biosimilar market provides qualitative and quantitative analysis for th…

    Worldwide Oncology Biosimilars Industry to 2026 - Featuring Biocon, Amgen and Sandoz International Among Others

    Dublin, Jan. 18, 2021 (GLOBE NEWSWIRE) -- The "Oncology Biosimilars Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's offering. The report on the global oncology biosimilars market provides qualitative and quantitat…
    Show more

    Biocon Frequently Asked Questions

    • When was Biocon founded?

      Biocon was founded in 1978.

    • Who are Biocon key executives?

      Biocon's key executives are John Shaw, Mary Harney and Vijay Kuchroo.

    • How many employees does Biocon have?

      Biocon has 7,995 employees.

    • Who are Biocon competitors?

      Competitors of Biocon include Idorsia, EMS Pharma and Biogen.

    • Where is Biocon headquarters?

      Biocon headquarters is located at Hosur Rd, Bengaluru.

    • Where are Biocon offices?

      Biocon has an office in Bengaluru.

    • How many offices does Biocon have?

      Biocon has 1 office.